Goal
A Quality of Earnings review can materially impact valuation, proceeds, and deal certainty. Learn how home-based care sellers can prepare before buyer diligence begins.
In home-based care M&A, many transactions that look promising at LOI fail to close or get materially re-traded during diligence. One of the most common reasons is what surfaces in financial diligence, specifically what a buyer’s Quality of Earnings review reveals about the durability of reported earnings.
For most operators, QoE only becomes a focus once a buyer is already at the table. By then, leverage has shifted. The buyer is asking the questions, and the seller is responding to them.
That is the wrong sequence.
Buyers do not pay for reported EBITDA. They pay for EBITDA they believe is normalized, recurring, transferable, and defensible. QoE is the process that determines how much of the seller’s financial story survives buyer scrutiny.
A QoE review answers a single question that drives nearly every other deal term:
How much of the company’s earnings can a buyer actually rely on after closing?
The answer dictates valuation, purchase price, deal structure, escrow size, working capital pegs, and ultimately the proceeds the seller takes home.
What a QoE Actually Reviews
A QoE is not a financial audit. It is a diligence process focused on the quality, accuracy, and sustainability of reported earnings. Buyers and their accounting advisors use it to evaluate revenue recognition, adjusted EBITDA, owner add-backs, non-recurring expenses, payroll and staffing economics, working capital trends, accounts receivable quality, customer and referral source concentration, payer mix, branch-level performance, margin stability, and any compliance exposure that may carry financial consequences.
In home health, hospice, and home care, those areas are not generic. They are shaped by reimbursement timing, labor markets, census volatility, payer behavior, and clinical documentation quality. A buyer’s QoE team will know exactly where to look — and they will look there first.
Why QoE Readiness Is a Leverage Issue, Not an Accounting One
The most common — and most expensive — mistake sellers make is assuming that strong revenue growth or strong reported EBITDA will speak for itself. It will not. Every number will be tested.
When buyers find issues, the consequences compound:
- Valuation reductions
- Larger escrows and indemnity holdbacks
- More aggressive working capital adjustments
- Extended diligence timelines and deal fatigue
- Reduced buyer confidence, often leading to re-trades after LOI
- Lower certainty of close
QoE issues do not just create accounting questions. They create negotiation risk. And in a market where the majority of LOIs in home-based care never reach close, that risk is the difference between a transaction and a process that collapses.
The Home-Based Care Issues That Matter Most
Buyers underwriting home health, hospice, and home care assets focus heavily on the details behind revenue and margin quality. The questions they bring to a QoE are predictable. Sellers who anticipate them keep control of the process.
Is revenue recognized appropriately? Buyers scrutinize billed versus unbilled revenue, revenue adjustments, denials, recoupments, and whether top-line trends are supported by clean documentation.
Is adjusted EBITDA defensible? Add-backs are challenged when they are poorly documented or when a buyer believes the underlying expense will continue post-close.
Are labor costs normalized? Contract labor, overtime, caregiver wages, clinician productivity, recruiting spend, and retention trends all shape margin quality.
Is AR collectible? Aged receivables, payer delays, denial trends, and write-off history affect both earnings and working capital simultaneously.
Is growth durable? Buyers evaluate census, admissions, referral source concentration, payer mix, and branch-level performance to determine whether growth is repeatable or tied to temporary tailwinds.
Are compliance risks embedded in the financials? Documentation, billing practices, eligibility, authorization workflows, and audit exposure all become financial diligence issues — even when they originate as clinical or operational ones.
These are not minor diligence items. They directly determine how a buyer values the business.
What Sellers Should Have Ready Before Diligence Begins
Sell-side readiness is built before launch, not after the LOI. By the time diligence begins, the financial story should already be supported by:
- Monthly revenue by payer
- Gross margin trends
- A documented adjusted EBITDA bridge
- A defensible add-back schedule with supporting evidence
- Payroll and staffing detail
- AR aging and collection history
- Denial and write-off trends
- Branch-level performance
- Census and admissions trends
- Referral source concentration analysis
- Working capital trends
- Non-recurring expense detail
- Owner compensation adjustments
- Related-party transaction disclosure
- TTM monthly P&L by entity, branch, and service line
- Revenue by payer and service line
- Census, admissions, discharges, and ADC trends
- Contract labor and overtime detail
- Bad debt, write-offs, denials, and recoupments
- Schedule of owner, related-party, and discretionary expenses
- Normalized compensation analysis
- Documentation of any non-recurring revenue or expense items
- Detail on any acquisitions, branch closures, or service line changes
- Reconciliation between billing system, EMR, and financial statements
Specific metrics relevant to home based care operations include the following:
- episodic versus hourly revenue
- Medicare versus Medicaid versus private pay exposure
- staffing model differences by branch
- visit utilization and clinician productivity
- hospice cap exposure
- home health LUPA, PDGM, recertification, and documentation issues
- caregiver availability and overtime in personal care
- revenue concentration by referral source or payer contract
The goal is not to eliminate every issue. The goal is to identify, quantify, and frame each issue before the buyer’s diligence team finds it first.
QoE Readiness Is a Deal Strategy Decision
A prepared seller enters diligence with confidence. An unprepared seller enters diligence on the defensive. That difference is rarely subtle, and it shows up in every term that matters.
When the financial story is clean, supported, and well organized, the buyer has fewer reasons to challenge valuation. The process moves faster. The seller controls the narrative. The buyer underwrites with confidence.
When the financial story is incomplete, inconsistent, or surprises the buyer mid-process, leverage shifts the other direction — typically in the form of lower valuation, more structure, larger holdbacks, expanded diligence, or pressure to renegotiate.
How a Sell-Side QoE Readiness Process Should Be Built
QoE readiness is not a single document or a one-week exercise. It is a sequenced process that ideally begins six to twelve months before going to market. Done well, it produces a financial story that holds up under sophisticated buyer diligence. Done poorly — or skipped — it cedes leverage before the first conversation.
A rigorous readiness process moves through five phases.
1. Build the adjusted EBITDA bridge before the buyer does. Reported EBITDA and adjusted EBITDA are not the same number, and the gap between them is where most diligence battles are fought. Sellers should construct a clear bridge — line by line — showing every adjustment, the rationale behind it, and the supporting evidence.
2. Stress-test every add-back against buyer logic. The test a buyer applies is simple: will this expense continue after closing? If the answer is yes, the add-back fails.
3. Normalize the labor model. In home-based care, labor is the largest line item and the most volatile.
4. Pressure-test the growth and concentration story. Sellers should be able to explain — with data — what is driving growth, whether it is repeatable.
5. Document the answers, do not just calculate them. Documentation transforms raw analysis into a diligence-ready financial story.
A seller who completes this process before launch does not eliminate diligence friction. They control where it lands, on what terms, and with how much leverage.
Final Takeaway
A Quality of Earnings review is where buyers determine whether reported financial performance is real, repeatable, and transferable. In home-based care, where the majority of executed LOIs never close, the cost of being unprepared is measured in lost valuation and lost certainty.
The numbers cannot simply be accurate. They have to be defensible.
QoE readiness is not a finance exercise. It is the foundation of a stronger transaction — and often the difference between a deal that closes on the seller’s terms and one that does not close at all.
Montauk AI helps home-based care operators prepare for buyer diligence before a transaction begins, so sellers can defend value, reduce surprises, and enter the market with a stronger financial story.
Montauk AI advises home-based care operators on sell-side readiness, valuation, and exit strategy.